Fritextsökning
Innehållstyper
-
Rickard Sandberg on this year’s Nobel Prize in Medicine: ”A key discovery”
The discovery that paved the way for the development of todays mRNA vaccines is the basis for this year’s Nobel Prize in Physiology or Medicine.
-
How to optimise your liquid handling results
In dispensing or pipetting applications in laboratory automation, it is important to obtain reliable results, which are analysed by calculating the accuracy and...
-
Cytel Inc acquires the SDS Group
The multinational statistical software developer and contract research organization Cytel Inc, headquartered in Massachusetts, USA, acquires the Swedish consult...
-
A new international stem cell research centre has been created in Copenhagen
A new centre for stem cell research opened to the public in January. The Novo Nordisk Foundation backs the initiative with the ambition that the centre will advance new medical technology and ...
-
Standardisation in automation
B. Braun Melsungen had a great idea and implemented it throughout the plant. Production for infusion solutions was to be largely standardised. B. Braun hoped th...
-
“We need to keep investing in research and innovation”
Jenni Nordborg has worked for just over four years to highlight life science in Sweden. Her mandate as national coordinator ends in December 2022. ““Life scienc...
-
Valves with piezo technology
Efficient control and regulation of gases in medical technology
-
40,000 DNA extractions daily
It's great when things run quickly: 20 minutes per extraction process and a new plate every 2.5 minutes – the Dutch company Synchron Lab Automation, in cooperat...
-
The pandemic caused a reshuffle among the world’s vaccine giants – here is the new top list
Fuelled by the pandemic, the power balance in the global vaccine market has completely changed in recent years, a survey from Fierce Pharma shows
-
Promising Alzheimer’s study data sends Bioarctic stock soaring
The drug candidate lecanemab from Swedish company Bioarctic significantly slowed down the deterioration in patients with early on-set Alzheimer’s, according to ...
-
Biosimilars bring price pressure, but are they sufficiently used?
When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...
-
Carl Borrebaeck – professor and serial entrepreneur with a taste for speed
Award-winning cancer researcher, the founder of many listed companies, and constantly in the academic and commercial spotlight for decades. However, Carl Borreb...
-
The fast route to a safe insulin pen
Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...
-
“An entire industry is about to be wiped out”
According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.
-
Delivering drugs with small devices
There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...
-
Anders Blanck about his 17 years at Lif: “The industry is enjoying greater public trust now"
The announcement came as a surprise to those around him, but according to the protagonist himself, the timing was excellent. Anders Blanck is now leaving Lif – ...
-
Företaget som gör apkoppsvaccin: Vi kan producera 30 miljoner doser
Det plötsliga utbrottet av apkoppor gör att ett stort antal länder världen över vill köpa det enda godkända vaccinet mot sjukdomen. Det tillverkas av ett företa...
-
Start-up developing ”digital twin” received award during the EIT Health Summit
A biotech company, a medtech company and a company in digital health were on the podium when the EIT Health Catapult awarded its winners.
-
Ingen efterfrågan på nya covidvaccinet – "Måste sannolikt kasseras"
Bara knappt sex tusen doser har hittills getts av covidvaccinet från Novavax i Sverige. Kvar i lager finns över 1,4 miljoner doser. "Det är sannolikt så att de ...
-
Första bekräftade dödsfallet i omikron i Storbritannien
Minst en person har dött i omikronvarianten i Storbritannien. Det uppger premiärminister Boris Johnson.
-
Calliditas vd efter historiska godkännandet: ”Idag ska vi fira”
Sent igår kväll fick Renée Aguiar-Lucander, vd för Calliditas Therapeutics, ett efterlängtat mejl från andra sidan Atlanten. Företagets läkemedel Tarpeyo hade b...
-
CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”
When the first CAR-T therapies appeared, hopes were raised for the effective treatment for critically ill cancer patients. After a somewhat sluggish start, abou...
-
Ny metod för mikroskopi öppnar genväg till nya läkemedel
Forskare vid Chalmers har utvecklat en helt ny mikroskopiteknik för att kunna studera de minsta biologiska partiklarna i sitt naturliga tillstånd – och därmed ö...
-
No demand for new Covid vaccine – “It will probably be discarded”
So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...
BREAKING